BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29664796)

  • 1. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.
    Pennington JD; Eilber FC; Eilber FR; Singh AS; Reed JP; Chmielowski B; Eckardt JJ; Bukata SV; Bernthal NM; Federman N; Nelson SD; Dry SM; Wang PC; Luu M; Selch MT; Steinberg ML; Kalbasi A; Kamrava M
    Am J Clin Oncol; 2018 Dec; 41(12):1154-1161. PubMed ID: 29664796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
    Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS
    Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant treatment with preoperative radiotherapy for extremity soft tissue sarcomas: long-term results from a single institution in Turkey.
    Dincbas FO; Oksuz DC; Yetmen O; Hiz M; Dervisoglu S; Turna H; Kantarci F; Mandel NM; Koca S
    Asian Pac J Cancer Prev; 2014; 15(4):1775-81. PubMed ID: 24641408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.
    Chowdhary M; Sen N; Jeans EB; Miller L; Batus M; Gitelis S; Wang D; Abrams RA
    Am J Clin Oncol; 2019 Jan; 42(1):1-5. PubMed ID: 29782358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
    Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT
    Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.
    Lu E; Perlewitz KS; Hayden JB; Hung AY; Doung YC; Davis LE; Mansoor A; Vetto JT; Billingsley KG; Kaempf A; Park B; Ryan CW
    Ann Surg Oncol; 2018 Apr; 25(4):920-927. PubMed ID: 29388122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
    Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
    Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall.
    Jebsen NL; Engellau J; Engström K; Bauer HC; Monge OR; Muren LP; Eide GE; Trovik CS; Bruland OS
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):949-55. PubMed ID: 23725998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience.
    Assi T; Cavalcanti A; Le Cesne A; Faron M; Honart JF; Hadiji A; Camuzard O; Ibrahim T; LePéchoux C; Mir O; Dumont S; Terrier P; Adam J; Honoré C
    Clin Transl Oncol; 2019 Sep; 21(9):1135-1141. PubMed ID: 30656606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
    Roeder F; Lehner B; Schmitt T; Kasper B; Egerer G; Sedlaczek O; Grüllich C; Mechtersheimer G; Wuchter P; Hensley FW; Huber PE; Debus J; Bischof M
    BMC Cancer; 2014 May; 14():350. PubMed ID: 24885755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
    Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective local control of advanced soft tissue sarcoma with neoadjuvant chemoradiotherapy and surgery: A single institutional experience.
    Stubbe F; Agaimy A; Ott O; Lettmaier S; Vassos N; Croner R; Hohenberger W; Fietkau R; Semrau S
    Cancer Radiother; 2016 Feb; 20(1):6-13. PubMed ID: 26700874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy.
    San Miguel I; San Julián M; Cambeiro M; Fernández Sanmamed M; Vázquez-García B; Pagola M; Gaztañaga M; Martín-Algarra S; Martinez-Monge R
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e529-39. PubMed ID: 21665380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
    Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
    Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
    Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
    JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
    Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
    Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
    Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
    BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.